Recurrent abdominal dislodgement of intrathecal pump and utility of infraclavicular site for patients with elevated body mass index: illustrative case
- PMID: 36692063
- PMCID: PMC10550701
- DOI: 10.3171/CASE22472
Recurrent abdominal dislodgement of intrathecal pump and utility of infraclavicular site for patients with elevated body mass index: illustrative case
Abstract
Background: Intrathecal baclofen, delivered via implanted pump, has been used to manage spasticity for approximately 40 years. The device is typically subcutaneously or subfascially implanted in the abdominal wall. There are very few cases reported of the pump being implanted in other locations.
Observations: This case describes the complicated course of a patient presenting with multiple episodes of catheter malfunction related to pump flipping in the abdominal pocket. The patient was successfully treated with repositioning of the pump into the infraclavicular fossa.
Lessons: Infraclavicular placement of the implanted pump allowed for a more secure pocket base for this patient and less strain applied to the pump, minimizing the risk of disruption of pump positioning and interruption of drug delivery.
Keywords: baclofen; infraclavicular; intrathecal; pump.
Conflict of interest statement
Figures
Similar articles
-
Infraclavicular fossa as an alternate site for placement of intrathecal infusion pumps: technical note.Neurosurgery. 2010 Feb;66(2):E402-3. doi: 10.1227/01.NEU.0000363597.56986.C4. Neurosurgery. 2010. PMID: 20087109
-
Bladder stones - red herring for resurgence of spasticity in a spinal cord injury patient with implantation of Medtronic Synchromed pump for intrathecal delivery of baclofen - a case report.BMC Urol. 2003 Mar 25;3:3. doi: 10.1186/1471-2490-3-3. Epub 2003 Mar 25. BMC Urol. 2003. PMID: 12659647 Free PMC article.
-
Unusual placement of intrathecal baclofen pumps: report of two cases.Acta Neurochir (Wien). 2016 Jan;158(1):167-70. doi: 10.1007/s00701-015-2636-9. Epub 2015 Nov 23. Acta Neurochir (Wien). 2016. PMID: 26592253 Free PMC article.
-
Intrathecal baclofen in cerebral palsy movement disorders.J Child Neurol. 1996 Nov;11 Suppl 1:S29-35. doi: 10.1177/0883073896011001S05. J Child Neurol. 1996. PMID: 8959459 Review.
-
Severe Neuromuscular Scoliosis Implicated by Dysfunction of Intrathecal Baclofen Pump: Case Report and Review of the Literature.World Neurosurg. 2020 Feb;134:390-395. doi: 10.1016/j.wneu.2019.11.027. Epub 2019 Nov 13. World Neurosurg. 2020. PMID: 31733394 Review.
References
-
- Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet. 1985;2(8447):125–127. - PubMed
-
- Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg. 1997;87(3):409–414. - PubMed
-
- Nuttin B, Ivanhoe C, Albright L, Dimitrijevic M, Saltuari L. Intrathecal baclofen therapy for spasticity of cerebral origin: cerebral palsy and brain injury. Neuromodulation. 1999;2(2):120–132. - PubMed
-
- Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol. 1996;11(suppl 1):S29–S35. - PubMed
-
- Gilmartin R, Bruce D, Storrs BB, et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol. 2000;15(2):71–77. - PubMed
LinkOut - more resources
Full Text Sources